Torq, the established Agentic AI security operations pioneer, today announced it has closed a massive $140 million Series D funding round, propelling its valuation to $1.2 billion and total funding to $332M. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112510774/en/ Led by Merlin Ventures—a leading cybersecurity fund renowned for its deep access to the U.S. commercial and Public Sector markets—with participation from all existi...
Ant International, a leading global payment, digitisation, and financial technology provider, is collaborating on the launch of Google’s Universal Commerce Protocol (UCP), a new open standard for agentic commerce that works across the entire shopping journey — from discovery and buying to post-purchase support. UCP establishes a common language for agents and systems to operate together across consumer surfaces, businesses, and payment providers to enable commerce. So instead of requiring uni...
FPT Software, the global IT services subsidiary of FPT Corporation (FPT), is positioned as a Leader in the IDC MarketScape: Asia/Pacific AI-Enabled Front Office Conversational AI Software 2025 Vendor Assessment (doc # AP52998625e, November 2025). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260111528290/en/ The IDC MarketScape evaluates 17 vendors in the Asia/Pacific region based on two major criteria: capability and strategy. Key...
The latest research from Omdia reveals that total shipments of desktops, notebooks and workstations in Q4 2025 grew 10.1% to 75 million units. This brought full-year 2025 PC shipments to 279.5 million units, a 9.2% increase over 2024 volumes. Notebook (including mobile workstation) shipments reached 58.6 million units in Q4 and 220.4 million units in the full year, achieving 8% growth in 2025. Desktop (including desktop workstation) shipments in Q4 landed at 16.2 million units, bringing the tot...
At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹ΨTP). The rapid growth of mRNA-based vaccines and therapeutics has driven significant demand for modified nucleotides like m¹ΨTP, which enhances mRNA stability and expression, while reducing immunogenicity. Enginzyme is a deep-tech company delivering optimized biomanufacturing solutions through cell-free ...